Best Blue Chip Stocks To Buy For 2023

When it comes to selecting dividend stocks to buy, investors can take their pick: high yield stocks, blue chip stocks with safe payouts, stocks with high dividend growth rates, value stocks; the list goes on.

But selecting undervalued dividend stocks is particularly advantageous for a variety of reasons, not the least of which is that dividend yield is higher when a stock’s price is lower, as they move inversely.

Here are 3 undervalued dividend stocks to buy for high total returns:

Triton International (NYSE:TRTN) Perrigo Company (NYSE:PRGO) LyondellBasell Industries (NYSE:LYB)

A low valuation also means a better chance for higher capital appreciation (in addition to the income received) when that undervalued stock sees its valuation multiples rise.

Dividend Stocks to Buy: Triton International (TRTN) Source: VladSV /

Our first stock is Triton International, a company that acquires, leases and sells intermodal containers and chassis to shipping lines, manufacturers and freight forwarders. Triton leases many types of containers including tanks, specialty, dry and refrigerated. It also trades in containers, buying and selling on the open market.

Best Blue Chip Stocks To Buy For 2023: Calamos Global Total Return Fund(CGO)

Calamos Global Total Return Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in a diversified portfolio of global equity, global convertible and below investment-grade (high-yield) fixed-income securities. It may purchase or write (sell) put and call options.

The Fund invests in sectors, such as information technology, consumer discretionary, financials, healthcare, consumer staples, energy, materials, telecommunication services, industrials and utilities. Calamos Advisors LLC serves as the Fund’s investment advisor.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cogeco (TSE:CGO) had its price objective lifted by research analysts at TD Securities from C$105.00 to C$110.00 in a research report issued to clients and investors on Friday. TD Securities’ target price indicates a potential upside of 44.13% from the company’s previous close.

  • [By Logan Wallace]

    Cogeco Inc. (TSE:CGO) reached a new 52-week low on Wednesday . The stock traded as low as C$57.73 and last traded at C$58.72, with a volume of 6659 shares. The stock had previously closed at C$58.29.

  • [By Shane Hupp]

    Cogeco Inc. (TSE:CGO) hit a new 52-week low on Monday . The stock traded as low as C$58.08 and last traded at C$58.12, with a volume of 14200 shares changing hands. The stock had previously closed at C$58.35.

Best Blue Chip Stocks To Buy For 2023: County Bancorp, Inc.(ICBK)

County Bancorp, Inc. (“we,” “us,” “our” or the “Company”) is a Wisconsin corporation founded in May 1996 and is registered as a bank holding company under the Bank Holding Company Act of 1956, as amended (the “BHCA”). Our primary activities consist of holding the stock of our wholly-owned subsidiary bank, Investors Community Bank (the “Bank”), and providing a wide range of banking and related business activities through the Bank and our other subsidiaries. At December 31, 2015, we had total assets of approximately $885 million. For additional financial information, see our Consolidated Financial Statements at Part II, Item 8 of this Form 10-K.
Investors Community Bank
Investors Community Bank is a Wisconsin state bank originally chartered in 1997, and headquartered in Manitowoc, Wisconsin.   Advisors’ Opinion:

  • [By ]

    Independent Bank Group (NASDAQ:IBTX) and County Bancorp (NASDAQ:ICBK) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

  • [By Shane Hupp]

    Guaranty Bancorp (NASDAQ:GBNK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on County Bancorp (ICBK)

    For more information about research offerings from Zacks Investment Research, visit

Best Blue Chip Stocks To Buy For 2023: Apricus Biosciences, Inc(APRI)

Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The company’s marketing partners for Vitaros include Laboratoires Majorelle, Bracco S.p.A., Hexal AG (Sandoz), Takeda Pharmaceuticals International GmbH, Recordati Ireland Ltd. (Recordati S.p.A.), Ferring International Center S.A. (Ferring Pharmaceuticals), Mylan NV, Neopharm Scientific Limited, Elis Pharmaceuticals Limited, and Global Harvest Pharmaceutical Corporation. It also develops second-generation Vitaros, a proprietary stabilized dosage formulation that is expected to be stored at room temperature conditions; and Fispemifene, a tissue-specific selective estrogen receptor modulator that is in Phase IIb clinical trial to treat secondary hypogonadism, lower urinary tract symptoms, and chronic prostatitis in men. In addition, the company plans to initiate a Phase IIb trial for RayVa to treat Raynaud’s phenomenon associated with scleroderma; and develops Femprox, a product candidate for the treatment of female sexual interest/arousal disorder. It operates in Latin America, Europe, and internationally. The company was formerly known as NexMed, Inc. and changed its name to Apricus Biosciences, Inc. in September 2010. Apricus Biosciences, Inc. was founded in 1987 and is headquartered in San Diego, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    LSI Industries, Inc. (NASDAQ:LYTS) Director John K. Morgan purchased 10,000 shares of the firm’s stock in a transaction on Wednesday, February 20th. The stock was bought at an average cost of $3.27 per share, with a total value of $32,700.00. Following the acquisition, the director now owns 35,880 shares of the company’s stock, valued at approximately $117,327.60. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

  • [By Joseph Griffin]

    LSI Industries, Inc. (NASDAQ:LYTS) CEO Ronald D. Brown acquired 5,000 shares of the business’s stock in a transaction on Monday, August 20th. The shares were bought at an average cost of $5.30 per share, with a total value of $26,500.00. Following the completion of the acquisition, the chief executive officer now owns 5,000 shares in the company, valued at $26,500. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Best Blue Chip Stocks To Buy For 2023: China Cord Blood Corporation(CO)


A. History and Development of the Company

We are a Cayman Islands company registered by way of continuation in the Cayman Islands on June 30, 2009.

CCBC was formed through a business combination (the “Business Combination”), which involved the merger of Pantheon China Acquisition Corp. (“Pantheon”) with and into Pantheon Arizona Corp. (“Pantheon Arizona”), then a wholly owned subsidiary of Pantheon formed for the purpose of effecting a merger, with Pantheon Arizona surviving the merger (the “Merger”) and the conversion and continuation of Pantheon Arizona’s corporate existence from Arizona to the Cayman Islands (the “Redomestication”).   Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Global Cord Blood Corp (NYSE:CO) dropped 5.8% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $9.05 and last traded at $9.34. Approximately 677,976 shares traded hands during mid-day trading, an increase of 222% from the average daily volume of 210,845 shares. The stock had previously closed at $9.92.

  • [By Motley Fool Staff]

    Global Cord Blood (NYSE:CO) Q4 2018 Earnings Conference CallJun. 27, 2018 8:00 a.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


Leave a Reply

Your email address will not be published.